SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-495275
Filing Date
2016-03-07
Accepted
2016-03-07 16:30:34
Documents
3
Period of Report
2016-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d153513d8k.htm 8-K 14905
2 EX-10.1 d153513dex101.htm EX-10.1 39353
3 GRAPHIC g153513ex10_1pg7.jpg GRAPHIC 162257
  Complete submission text file 0001193125-16-495275.txt   279191
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 161488857
SIC: 2835 In Vitro & In Vivo Diagnostic Substances